{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T23:53:47Z","timestamp":1785196427416,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Organization for Rare Diseases","award":["707338"],"award-info":[{"award-number":["707338"]}]},{"name":"Pseudomyxoma Peritonei Philanthropic Research Fund, Division of Surgical Oncology, University of Pittsburgh"},{"name":"David C. Koch Regional Therapy Cancer Center, University of Pittsburgh"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NCI","award":["CA140554"],"award-info":[{"award-number":["CA140554"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P30CA047904"],"award-info":[{"award-number":["P30CA047904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","translationalres.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.trsl.2015.03.004","type":"journal-article","created":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T06:13:44Z","timestamp":1429251224000},"page":"344-354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Mitogen-activated protein kinase inhibition reduces mucin 2 production and mucinous tumor growth"],"prefix":"10.1016","volume":"166","author":[{"given":"Ashok K.","family":"Dilly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert J.","family":"Zeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong S.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroon A.","family":"Choudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2015.03.004_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12182","article-title":"The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system","volume":"260","author":"Pelaseyed","year":"2014","journal-title":"Immunol Rev"},{"key":"10.1016\/j.trsl.2015.03.004_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1750-1172-9-71","article-title":"Secreted mucins in pseudomyxoma peritonei: pathophysiological significance and potential therapeutic prospects","volume":"9","author":"Amini","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.trsl.2015.03.004_bib3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1440-1827.2007.02137.x","article-title":"MUC2, MUC5AC and MUC5B in the mucus of a patient with pseudomyxoma peritonei: biochemical and immunohistochemical study","volume":"57","author":"Mall","year":"2007","journal-title":"Pathol Int"},{"key":"10.1016\/j.trsl.2015.03.004_bib4","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1097\/01.MP.0000026617.52466.9F","article-title":"MUC2 is a molecular marker for pseudomyxoma peritonei","volume":"15","author":"O'Connell","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.trsl.2015.03.004_bib5","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0002-9440(10)64211-3","article-title":"Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells","volume":"161","author":"O'Connell","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2015.03.004_bib6","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/jso.23146","article-title":"Mucin as a therapeutic target in pseudomyxoma peritonei","volume":"106","author":"Choudry","year":"2012","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.trsl.2015.03.004_bib7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/jamp.2009.0802","article-title":"New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways","volume":"23","author":"Lai","year":"2010","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.trsl.2015.03.004_bib8","first-page":"D1216","article-title":"Transcriptional regulation of the 11p15 mucin genes. Towards new biological tools in human therapy, in inflammatory diseases and cancer?","volume":"6","author":"Van Seuningen","year":"2001","journal-title":"Front Biosci"},{"key":"10.1016\/j.trsl.2015.03.004_bib9","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.1073\/pnas.95.10.5718","article-title":"Activation of NF-kappaB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells","volume":"95","author":"Li","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2015.03.004_bib10","doi-asserted-by":"crossref","first-page":"32258","DOI":"10.1074\/jbc.M204862200","article-title":"Induction of MUC2 and MUC5AC mucins by factors of the epidermal growth factor (EGF) family is mediated by EGF receptor\/Ras\/Raf\/extracellular signal-regulated kinase cascade and Sp1","volume":"277","author":"Perrais","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2015.03.004_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/gm559","article-title":"Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin","volume":"6","author":"Alakus","year":"2014","journal-title":"Genome Med"},{"key":"10.1016\/j.trsl.2015.03.004_bib12","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1245\/s10434-012-2242-5","article-title":"Chronic anti-inflammatory drug therapy inhibits gel-forming mucin production in a murine xenograft model of human pseudomyxoma peritonei","volume":"19","author":"Choudry","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.trsl.2015.03.004_bib13","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/modpathol.2014.37","article-title":"Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade","volume":"27","author":"Davison","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.trsl.2015.03.004_bib14","doi-asserted-by":"crossref","first-page":"8435","DOI":"10.1158\/0008-5472.CAN-10-1506","article-title":"K-ras mutation targeted to gastric tissue progenitor cells results in chronic inflammation, an altered microenvironment, and progression to intraepithelial neoplasia","volume":"70","author":"Okumura","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2015.03.004_bib15","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bbrc.2007.03.025","article-title":"The short chain fatty acid, butyrate, stimulates MUC2 mucin production in the human colon cancer cell line, LS174T","volume":"356","author":"Hatayama","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2015.03.004_bib16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1432-0436.2006.00074.x","article-title":"The intestine-specific homeobox gene Cdx2 induces expression of the basic helix-loop-helix transcription factor Math1","volume":"74","author":"Mutoh","year":"2006","journal-title":"Differentiation"},{"key":"10.1016\/j.trsl.2015.03.004_bib17","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/labinvest.2012.56","article-title":"Notch signaling pathway and Cdx2 expression in the development of Barrett's esophagus","volume":"92","author":"Tamagawa","year":"2012","journal-title":"Lab Invest"},{"key":"10.1016\/j.trsl.2015.03.004_bib18","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0006-291X(02)02935-2","article-title":"Homeodomain protein CDX2 regulates goblet-specific MUC2 gene expression","volume":"300","author":"Yamamoto","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2015.03.004_bib19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1756-8722-3-8","article-title":"From basic research to clinical development of MEK1\/2 inhibitors for cancer therapy","volume":"3","author":"Fremin","year":"2010","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.trsl.2015.03.004_bib20","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1158\/0008-5472.CAN-09-0679","article-title":"RDEA119\/BAY 869766: a potent, selective, allosteric inhibitor of MEK1\/2 for the treatment of cancer","volume":"69","author":"Iverson","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2015.03.004_bib21","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.bbamcr.2006.11.009","article-title":"Clinical experience of MEK inhibitors in cancer therapy","volume":"1773","author":"Wang","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.trsl.2015.03.004_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1517\/14728222.2011.645805","article-title":"Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy","volume":"16","author":"Santarpia","year":"2012","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.trsl.2015.03.004_bib23","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1245\/s10434-012-2241-6","article-title":"Aggressive management of peritoneal carcinomatosis from mucinous appendiceal neoplasms","volume":"19","author":"Austin","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.trsl.2015.03.004_bib24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1470-2045(05)70539-8","article-title":"New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?","volume":"7","author":"Sugarbaker","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.trsl.2015.03.004_bib25","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/cncr.24715","article-title":"Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin a single-institution experience","volume":"116","author":"Shapiro","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.trsl.2015.03.004_bib26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.tice.2011.03.002","article-title":"Caco-2 and LS174T cell lines provide different models for studying mucin expression in colon cancer","volume":"43","author":"Bu","year":"2011","journal-title":"Tissue Cell"},{"key":"10.1016\/j.trsl.2015.03.004_bib27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2613.2010.00721.x","article-title":"Establishment and characterization of a murine xenograft model of appendiceal mucinous adenocarcinoma","volume":"91","author":"Mavanur","year":"2010","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.trsl.2015.03.004_bib28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1042\/BJ20082222","article-title":"The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection","volume":"420","author":"Burger-van Paassen","year":"2009","journal-title":"Biochem J"},{"key":"10.1016\/j.trsl.2015.03.004_bib29","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/sj.leu.2402945","article-title":"Signal transduction mediated by the Ras\/Raf\/MEK\/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention","volume":"17","author":"Chang","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.trsl.2015.03.004_bib30","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","article-title":"Targeting the Raf-MEK-ERK mitogen-activated\u00a0protein kinase cascade for the treatment of cancer","volume":"26","author":"Roberts","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.trsl.2015.03.004_bib31","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1128\/MCB.24.17.7806-7819.2004","article-title":"NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity","volume":"24","author":"Fujioka","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.trsl.2015.03.004_bib32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1053\/j.seminoncol.2006.04.005","article-title":"New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors","volume":"33","author":"Faivre","year":"2006","journal-title":"Semin Oncol"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524415001073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524415001073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T12:52:24Z","timestamp":1537707144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524415001073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1931524415001073"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2015.03.004","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitogen-activated protein kinase inhibition reduces mucin 2 production and mucinous tumor growth","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2015.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}